X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-04-11 | THRD | Holles Natalie C. | CEO | S - Sale+OE | $12.19 | -13,558 | 1,218,836 | -1% | -$165,214 | |||||
| D | 2024-04-04 | THRD | Person Julie | Chief Administrative Officer | S - Sale+OE | $10.00 | -1,107 | 0 | -100% | -$11,070 | |||||
| D | 2023-12-05 | THRD | Person Julie | Chief Administrative Officer | S - Sale+OE | $10.30 | -12,863 | 0 | -100% | -$132,484 | |||||
| D | 2023-12-05 | THRD | Conner Edward R. | Chief Medical Officer | S - Sale+OE | $10.03 | -4,790 | 0 | -100% | -$48,062 | |||||
2022-12-20 | THRD | Bvf Partners L P/il | 10% | P - Purchase | $4.11 | +214,063 | 241,309 | +786% | +$879,499 | ||||||
| D | 2022-09-19 | THRD | Orbimed Advisors LLC | Dir, 10% | P - Purchase | $17.00 | +300,000 | 5,779,071 | +5% | +$5,100,000 | |||||
| D | 2022-09-19 | THRD | Bonita David P | Dir, 10% | P - Purchase | $17.00 | +300,000 | 5,779,071 | +5% | +$5,100,000 | |||||
| D | 2022-09-19 | THRD | Atlas Venture Fund Xi, L.P. | 10% | P - Purchase | $17.00 | +300,000 | 594,096 | +102% | +$5,100,000 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |